The global spinal surgery devices market is expected to grow at a Compound Annual Growth Rate (CAGR) of 4% from $6.5 billion in 2011 to $8.7 billion in 2018.
Medical companies bend over backwards to meet need for advanced spinal surgery devices and the market for spinal surgery devices is being driven forward, as patients are offered safer, more
reliablesurgery that will preserve natural movement and prevent degeneration of the spine and this new report looks at spinal surgery devices, which are used for the treatment of lower back pain caused by degenerative disorders, trauma and sports injuries.
Spinal non-fusion
Motion-preservation techniques in spinal non-fusion procedures are predicted to be the next big thing in spinal surgery, and have seen enhanced adoption rates over the last few years. Following developments in the understanding of spinal physiology, anatomy and spinal biomechanics, innovative techniques can now maintain spinal mobility while treating spinal degeneration, and a number of manufacturers have developed motion-preserving devices to exploit this growing trend.
While spinal fusion has remained the gold standard for the treatment of spinal degenerative disorders, it can cause restriction of motion and degeneration of adjacent spinal segments through stress which can further delay recovery and in some cases, even lead to unwanted additional back surgery. This has led surgeons and patients to adopt spinal non-fusion or motion-preserving technologies, which maintain the patient’s spinal mobility while alleviating severe back and leg pain. The ability of the spine to be mobile and stable after intensive surgical procedures makes it preferred over fusion procedures, and advances in non-fusion procedures alleviate pain and restore motion despite enduring heavy loads, offering clinical benefits over arthrodesis or spinal joint fusion.
Spinal non-fusion technology is experiencing rapid advances, with advanced technologies leading to the introduction of new devices, such as artificial disc replacement (ADR), dynamic stabilization and Interspinous Process Decompression (IPD) devices. ADR involves the replacement of the damaged natural disc with an artificial disc without compromising the mobility of the spine, while stabilization devices treat back pain by restricting motion in certain areas while allowing motion in adjacent vertebral segments.
Minimally Invasive Spinal Surgery (MISS) can be used to implant these devices, and surgeons are finding a number of clinical benefits. Traditional open spinal surgery requires a large incision to be made in the back or abdomen, requiring the expertise of specialized vascular surgeons and risking serious injury. Large incision scars and surgical complications such as excessive blood loss and severe post-operative pain all lead to significant hospital stays and recovery periods.
Source:RnRMarketResearch.com (http://www.rnrmarketresearch.com/)
Minimally invasive (MI) Spine Technologies
Despite some significant downward pressures, the United States market for minimally invasive (MI) spine technologies will grow strongly, reaching nearly $2 billion by 2017. Most of this growth will come from expansion of the largest segment, the minimally invasive spinal fusion market, but the less mature facet fixation segment will also experience significant revenue growth.
Some physicians, however, remain cautious because MI spine techniques require extensive training; a lack of familiarity can negatively affect outcomes as well as increase procedure time. In addition, some physicians also highlight a shortage of clinical data supporting both the short- and long-term efficacy of these procedures, which has led to a lack of reimbursement for some products.
A number of MI spinal fusion clinical trials currently ongoing may change the environment for MI spine technology. One example is NuVasive’s study comparing traditional open posterior lumbar interbody fusion (PLIF) with NuVasive’s MI Maximum Access Surgery PLIF variant, which is expected to be complete by 2014. Favorable results in this study and others like it are expected to positively influence the volume of minimally invasive procedures involving spinal technologies.
“Facet fixation will be the fastest growing segment in this market,” said MRG Analyst Rene Azeez. “This growth is primarily because companies are increasing efforts to provide surgeons with training. The relative simplicity and minimally invasive nature of the surgery, coupled with favorable reimbursement and mounting favorable clinical evidence all support its adoption. We’ll see a number of innovative products introduced, such as VG Innovations’ VerteLoc v 2.5, which claims to improve ease‐of‐use and facilitate enhanced patient outcomes.”While NuVasive is the current market leader, competition will intensify as other companies recognize the enormous potential of this market, particularly in lucrative high-growth segments such as facet fixation and MI transforaminal lumbar interbody fusion (TLIF) and lateral lumbar interbody fusion (LLIF).
Source: Millennium Research Group (MRG)
Europe
The European minimally invasive surgery spinal implant market is expected to exceed 92 million by 2018. The European market for (MIS) spinal implants includes MIS interbody fusion and MIS pedicle screws. Growth is expected in both segments of the European MIS spinal implant market as a result of the physiological and surgical advantages of MIS procedures. In 2011, MIS pedicle screws represented the larger of the two segments, with a majority share of over 65%.
Source: Research and Markets